title: Therapeutic Vaccination against A Modified Minimal Survivin Epitope Induces Functional CD4 T Cells That Recognize Survivin-Expressing Cells.
authors.affiliation: Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.
authors.forename: N J
authors.initials: NJ
authors.lastname: Nitschke
authors.affiliation: Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.|Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
authors.forename: J
authors.initials: J
authors.lastname: Bjoern
authors.affiliation: Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.|Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
authors.forename: O
authors.initials: O
authors.lastname: Met
authors.affiliation: Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.|Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
authors.forename: I M
authors.initials: IM
authors.lastname: Svane
authors.affiliation: Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, Denmark.|Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
authors.forename: M H
authors.initials: MH
authors.lastname: Andersen
mesh_terms: D000595:Amino Acid Sequence; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D019496:Cancer Vaccines / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D018984:Epitopes, T-Lymphocyte / Q000235:genetics / Q000276:immunology; D005786:Gene Expression Regulation; D015789:HLA-A2 Antigen / Q000235:genetics / Q000276:immunology; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D007371:Interferon-gamma / Q000494:pharmacology; D008545:Melanoma / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D009842:Oligopeptides / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D061251:Primary Cell Culture; D012878:Skin Neoplasms / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D000077022:Survivin; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000276:immunology; D014611:Vaccination
chemical_list: C107489:BIRC5 protein, human; D019496:Cancer Vaccines; D018984:Epitopes, T-Lymphocyte; D015789:HLA-A2 Antigen; C573415:IFNG protein, human; D051034:Inhibitor of Apoptosis Proteins; D009842:Oligopeptides; D000077022:Survivin; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma